Jefferies & Company Reiterates Hold Rating, $38 PT for St. Jude Medical


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


In a report published earlier today, Jefferies & Company, Inc. reiterated its Hold rating and $38.00 for St. Jude Medical, Inc. (NYSE: STJ).Jefferies went on to say “STJ issued a release on Friday with its findings on the Durata failure recently reported in FDA's MAUDE database. After examining the lead at the hospital in FL where it was removed, the root cause was found to be external abrasion and not the more damning insideout mode. While the company's findings maintain Durata's pristine record with inside-out externalizations, concern over STJ ICD leads persists and we maintain our Hold rating.”St. Jude Medical, Inc. closed on Friday at $37.90.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorReiterationAnalyst RatingsJefferies & Company Inc.